National Institutes of Health (NIH) researchers have developed a digital replica of crucial eye cells, providing a new tool for studying how the cells organize themselves when they are healthy and affected by diseases. The ...
13 hours ago
0
0
The popular diabetes and weight loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a leading cause of vision loss, according to Weill Cornell Medicine investigators. ...
14 hours ago
0
0
People who use injection drugs are at a higher risk for eye infections, particularly endogenous endophthalmitis—a medical emergency caused by bacteria or fungi entering the bloodstream to reach the inside of the eye. These ...
22 hours ago
0
0
More than 94 million people suffer from cataracts, but half of them do not have access to the surgery needed to fix it, the World Health Organization said Wednesday.
Feb 11, 2026
0
0
The risk for neovascular age-related macular degeneration (nAMD) seems not to be increased following cataract surgery, according to a research letter published online Feb. 5 in JAMA Ophthalmology.
Feb 10, 2026
0
0
Cells from cancerous tumors can spread, or metastasize, throughout the body. Researchers have long sought to understand what determines where those cells will go and thrive in order to more effectively treat the cancer and ...
Feb 9, 2026
0
29
The U.S. Food and Drug Administration has approved Yuvezzi (carbachol and brimonidine tartrate) ophthalmic solution 2.75%/0.1%, previously known as Brimochol PF, as the first and only dual-agent eye drop for the treatment ...
Feb 5, 2026
0
0
When you go for a walk, how does your brain know the difference between a parked car and a moving car? This seemingly simple distinction is challenging because eye movements, such as the ones we make when watching a car pass ...
Feb 4, 2026
0
18
A team led by UCL researchers with Great Ormond Street Hospital (GOSH) and Moorfields Eye Hospital, found B cells—alongside T cells—play a key role in arthritis-related eye disease (JIA uveitis), a condition that can ...
Feb 4, 2026
0
7
A research team has successfully demonstrated the world's first gene-editing treatment for Leber's hereditary optic neuropathy (LHON). The study was conducted in collaboration with the Seoul National University College of ...
Feb 4, 2026
0
0
